Stocktoria
Nano Labs Ltd NA
Nano Labs Ltd financials (annual)
Bars are annual figures from 2021 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $3.8M | $5.6M | $11.1M | $983.2M | $39.4M |
| Gross profit | -$5.7M | $1.6M | -$14.6M | $33.0M | -$4.1M |
| R&D expense | $1.1M | $7.0M | $12.5M | $18.9M | $145.5M |
| Operating income | $10.2M | -$13.7M | -$36.8M | $3.0M | -$178.8M |
| Income tax | — | — | -$2,456 | $0 | $0 |
| Net income | $19.3M | -$15.7M | -$35.7M | $4.5M | -$174.9M |
| EPS (diluted) | $0.97 | $-1.96 | $-0.61 | $0.04 | $-3.89 |
| Operating cash flow | -$15.4M | -$19.4M | -$18.8M | -$39.5M | $71.7M |
| Free cash flow | -$15.4M | -$24.4M | -$33.7M | -$42.0M | $63.0M |
| Cash & equivalents | $1.2M | $4.5M | $6.8M | $12.6M | $233.9M |
| Inventory | $1.9M | $4.2M | $1.8M | $14.7M | $213.9M |
| Total assets | $159.3M | $85.7M | $49.5M | $52.7M | $909.8M |
| Total liabilities | $53.9M | $53.3M | $51.8M | $29.1M | $934.5M |
| Shareholders' equity | $106.5M | $32.4M | -$2.3M | $23.6M | -$24.7M |
Growth · year-over-year · Revenue CAGR -44.1%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue growth | -32.0% | -48.9% | -98.9% | +2392.8% | — |
| Net income growth | — | — | -898.9% | — | — |
| EPS growth | — | — | -1625.0% | — | — |
| Free cash flow growth | — | — | — | -166.6% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.